Amberly Brigden

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Amberly Bridgen is a UK researcher and lead author for the MAGENTA trial, a graded exercise therapy (GET) program for teenagers and adolescents.

Notable studies[edit | edit source]

  • 2016, Managed Activity Graded Exercise iN Teenagers and pre-Adolescents (MAGENTA) feasibility randomised controlled trial: study protocol[1]

Clinic location[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

  • PubMed
  • Twitter
  • Facebook
  • Website
  • YouTube
  • Address: clinic/lab-address-goes-here ()

See also[edit | edit source]

Learn more[edit | edit source]

  • Wikipedia
  • Institution

References[edit | edit source]

Graded exercise therapy (GET) - A gradual increase in exercise or activity, according to a pre-defined plan. Focuses on overcoming the patient's alleged unhelpful illness beliefs that exertion can exacerbate symptoms, rather than on reversing physical deconditioning. Considered controversial, and possibly harmful, in the treatment or management of ME. One of the treatment arms of the controversial PACE trial.

Randomized controlled trial (RCT) - A trial in which participants are randomly assigned to two groups, with one group receiving the treatment being studied and a control or comparison group receiving a sham treatment, placebo, or comparison treatment.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.